Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2200246	氨磺必利片	amisulpride	Tablet	Chemical Drugs	License Renew	2022-09-09		Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Delpharm Dijon			view
JYHZ2200245	氨磺必利片	amisulpride	Tablet	Chemical Drugs	License Renew	2022-09-09		Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Delpharm Dijon			view
JYHZ1800162	氨磺必利片	amisulpride	Tablet	Chemical Drugs	License Renew	2018-06-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2018-11-26	view
JYHZ1800161	氨磺必利片	amisulpride	Tablet	Chemical Drugs	License Renew	2018-07-11	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2018-11-26	view
JYHF1900049	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2019-04-02	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2019-04-23	view
JYHB2400058	氨磺必利片	amisulpride	Tablet	Chemical Drugs(5.1)	Supplementary Application	2024-02-02		Delpharm Dijon;Sanofi Winthrop Industrie			view
JYHB2400057	氨磺必利片	amisulpride	Tablet	Chemical Drugs(5.1)	Supplementary Application	2024-02-02		Delpharm Dijon;Sanofi Winthrop Industrie			view
JYHB2300688	氨磺必利片	amisulpride	Tablet	Chemical Drugs(5.1)	Supplementary Application	2023-11-28		Sanofi-Aventis France;Delpharm Dijon			view
JYHB2001874	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2020-09-25	赛诺菲 (杭州）制药有限公司	Sanofi (Hangzhou) Pharmaceutical Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Filed	2020-10-16	view
JYHB2000528	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2020-05-10	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2020-06-18	view
JYHB1901027	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2019-08-16	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2020-06-22	view
JYHB1901026	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2019-08-29	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2020-06-22	view
JYHB1800069	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2018-02-09	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Filed	2018-02-26	view
JYHB1701044	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2017-08-03	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2017-09-28	view
JYHB1701043	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2017-08-17	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Delpharm Dijon	Certificate Issued	2017-09-28	view
JYHB1000482	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2010-06-11	赛诺菲安万特（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Sanofi Winthrop Industrie	Certificate Issued	2011-01-05	view
JYHB0500318	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2005-05-19	法国赛诺菲圣德拉堡集团中国分公司北京办事处	Sanofi Synthelabo;Sanofi Winthrop Industrie	Certificate Issued	2006-05-30	view
J0401890	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Supplementary Application	2004-10-12			Certificate Issued	2005-04-15	view
H20000363	氨磺必利片	amisulpride	Tablet	Chemical Drugs	Import Drug Application	2001-02-26	法国赛诺菲圣德拉堡集团中国分公司		Approval Completed-Pending Certificated	2001-12-17	view
CYHS2200205	氨磺必利片	amisulpride	Tablet	Chemical Drugs(4)	Generic Drug	2022-01-27		Jiangsu Vanguard Pharmaceutical Co Ltd;Fujian Boro Pharmaceutical Research Co Ltd			view